Literature DB >> 8399877

Epidemic meningococcemia and purpura fulminans with induced protein C deficiency.

D Powars1, R Larsen, J Johnson, T Hulbert, T Sun, M J Patch, R Francis, L Chan.   

Abstract

Patients with epidemic infections caused by Neisseria meningitidis serogroup C were studied to assess the relationship of abnormal coagulation parameters to prognosis. Patients were categorized into stages within the first hour of observation according to severity of illness. During the epidemic years 1986 through 1991, 113 patients with bacteriologically proven N. meningitidis infection were observed, 15 of whom died. Purpura fulminans was seen in 28 patients, of whom 14 (50%) died. Among the 14 surviving patients who had purpura fulminans, 10 suffered gangrene with deforming autoamputation secondary to the dermal microvascular thrombosis and hemorrhagic necrosis. Evaluation of the induced diffuse intravascular coagulation in 59 patients included studies of the naturally occurring anticoagulants, focusing on protein C and protein S. The magnitude of the declining levels of protein C, the degree of thrombocytopenia, and the presence of fibrin split products are directly related to the clinical severity of the illness (P = .0053). Thus, in individuals with severe disease expression, the risk of purpura fulminans with death or deformity was significantly increased when the platelet count was < 50,000 cells/mm3 (P = .0001) and protein C levels were low (P = .0158). The immaturity of the protein C system in children who are < 4 years of age may contribute to the rapid and more frequent pathogenesis of purpura fulminans. Therapy directed at replacement of the naturally occurring anticoagulants, such as protein C, may ultimately improve the prognosis for individuals with purpura fulminans.

Entities:  

Mesh:

Year:  1993        PMID: 8399877     DOI: 10.1093/clinids/17.2.254

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

Review 1.  Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity.

Authors:  Emanuel P Rivers; Lauralyn McIntyre; David C Morro; Kandis K Rivers
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

Review 2.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 3.  The problem of sepsis. An expert report of the European Society of Intensive Care Medicine.

Authors: 
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

4.  Protein C as an early marker of severe septic complications in diffuse secondary peritonitis.

Authors:  Aleksandar Karamarkovic; Dejan Radenkovic; Natasa Milic; Vesna Bumbasirevic; Branislav Stefanovic
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

5.  The role of protein C in sepsis.

Authors:  Mark R Looney; Michael A Matthay
Journal:  Curr Infect Dis Rep       Date:  2007-10       Impact factor: 3.725

6.  A normal platelet count at admission in acute meningococcal disease does not exclude a fulminant course.

Authors:  M Van Deuren; C Neeleman; L G Van 't Hek; J W Van der Meer
Journal:  Intensive Care Med       Date:  1998-02       Impact factor: 17.440

7.  Guidance on patient identification and administration of recombinant human activated protein C for the treatment of severe sepsis.

Authors:  Gary Garber; Rt Noel Gibney; Bruce Light; Claudio Martin; Kenneth Cunningham; Jean-Gilles Guimond; Sheldon Magder; James Russell
Journal:  Can J Infect Dis       Date:  2002-11

8.  Spectrum of purpura fulminans.

Authors:  A V Lalitha; D Aruna; Anand Prakash; H M Nanjunda Swamy; S D Subba Rao
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

9.  Fulminant meningococcal septic shock in a boy with combined inherited properdin and protein C deficiency.

Authors:  C A Fijen; B H Derkx; E J Kuijper; M Mannens; S R Poort; M Peters; M R Daha; J Dankert
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

10.  Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin-antithrombin complex.

Authors:  K Høgåsen; T E Mollnes; P Brandtzaeg
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.